Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease
2024 · State University of New York - Upstate Medical University
This article describes the challenges and advancements in protecting infants from serious RSV disease. It highlights the unpredictability of RSV, especially during the COVID-19 pandemic, …
New and Emerging Passive Immunization Strategies for the Prevention of RSV Infection During Infancy
2024 · State University of New York - Upstate Medical University
This article discusses new ways to protect babies from RSV, a virus causing lung infections. Two methods were approved in 2023: one uses a long-lasting …
Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials
2023 · Children's Hospital Colorado, · University of the Witwatersrand, · Northwestern University, · Dr. Georgi Stranski University Hospital, · Quironsalud Madrid University Hospital, · State University of New York - Upstate Medical University
This article describes a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) infections in infants. It focuses on both preterm and …
Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers
2023 · University of Washington, · State University of New York - Upstate Medical University, · Seattle Children's Hospital
This article provides an update on respiratory syncytial virus (RSV) for prenatal and primary health providers. It emphasizes the lack of data on RSV infection …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie